^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    XH-30002

    i
    Other names: XH-30002, JRF104
    Associations

    News

    Trials
    Company:
    Jinrui Foundation
    Drug class:
    CDK4 inhibitor
    Related drugs:
    Associations

    News

    Trials
    over2years
    XH-30002 Capsule Combined With Afatinib Tablets for the Treatment of Squamous Cell Carcinoma (clinicaltrials.gov)
    P1, N=20, Not yet recruiting, Fujian Cancer Hospital
    New P1 trial • Metastases
    |
    Gilotrif (afatinib) • XH-30002